Latest Ipo And Funding News

Almasar Minerals ended its first post-listing quarter with A$10.24 million in cash and a pipeline of geophysical surveys and auger drilling across its Saudi Arabian licences. The company has yet to report new exploration results, leaving execution and target quality as the next tests for the newly listed explorer.

Neu Horizon Uranium has completed its first major Swedish uranium exploration campaign since listing, generating more than 12,000 line kilometres of airborne data and preparing a maiden drill programme at Storvallflon. The ASX newcomer ended September with A$8.623 million in cash, while assays and target interpretations remain pending.

Daly Resources has emerged from its June ASX debut with $11.05 million in cash, a 6,500 km² Northern Territory exploration portfolio and a growing list of drill targets. The catch is familiar for early-stage explorers: the company has yet to define a mineral resource or reserve, while its strongest Huckitta results remain surface sampling rather than drilling.

Chilwa Minerals has lodged a prospectus supporting a fully underwritten US$3.5 million Nasdaq IPO, with most of the proceeds earmarked for exploration at its Chilwa Critical Minerals Project. The raising would strengthen its cash position, but the prospectus also flags material going-concern uncertainty and further funding needs.

Barkly Rare Earths has entered its first full year as an ASX-listed explorer with A$5.38 million in cash, a 10,000-metre drilling programme underway and an early 99% magnet rare earth oxide extraction result. The technical signals are encouraging, but both the drilling data and metallurgy remain at an early stage.

Almasar Minerals Limited (ASX:AMK) is launching an IPO to fund early-stage exploration across five licences in Saudi Arabia’s Arabian Shield, targeting gold and copper mineralisation.

L1 Long Short Fund Limited (ASX:LSF) posted a standout FY26 with a 45.4% net portfolio return, driving a 538% jump in net profit after tax to $635 million and a 22% CAGR in dividends since IPO. The fund also released its inaugural climate-related disclosures, affirming resilience amid evolving risks.

Powerhaus Uranium launches an IPO to raise up to A$10 million, aiming to accelerate uranium exploration in underexplored Argentine provinces and acquire a Canadian Athabasca Basin project. The company’s flagship Malbec Project shows promising early-stage results, with plans for extensive drilling and in-situ recovery methods.

Epiminder has leveraged its $125 million IPO to advance clinical enrolments, boost Medicare reimbursement, and develop its next-generation Minder device, positioning for a commercial launch in early 2028.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

L1 Long Short Fund Limited (ASX:LSF) has declared a fully franked 3.7 cent dividend, continuing a trend of rising payouts amid a standout 44.7% net return over the past year, significantly outperforming the ASX200AI benchmark.